FASEB J. Avanti Polar Lipids
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gottschall, P. E.
Right arrow Articles by Arimura, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gottschall, P. E.
Right arrow Articles by Arimura, A.

The FASEB Journal, Vol 2, 2492-2496, Copyright © 1988 by The Federation of American Societies for Experimental Biology

RESEARCH COMMUNICATIONS

Interleukin 1: an inhibitor of luteinizing hormone receptor formation in cultured rat granulosa cells

PE Gottschall, G Katsuura, ST Hoffmann and A Arimura
U.S.-Japan Biomedical Laboratories, Tulane University Hebert Center, Belle Chasse, Louisiana 70037.

We have shown that interleukin 1 (IL 1) suppresses follicle-stimulating hormone (FSH)-induced progesterone secretion and 125I-labeled human chorionic gonadotropin (hCG) binding (a measurement of LH receptors) in cultured rat granulosa cells. The present study was designed to examine if the reduction of FSH-stimulated 125I-labeled hCG binding by IL 1 was caused by a decline in the binding capacity or by an alteration in the affinity of the LH receptor and, further, to determine the minimum period of exposure of the granulosa cells to IL 1 necessary to suppress 125I-labeled hCG binding. IL 1 produced a dose-dependent inhibition of 125I-labeled hCG binding in FSH-stimulated granulosa cells. Scatchard analysis revealed that this effect resulted from a reduction of the binding capacity of the LH receptor with no change in affinity. Also, a minimum of 12-24 h of exposure to IL 1 is necessary to significantly inhibit FSH-induced LH receptor formation. These results suggest that IL 1 decreases the number of LH receptors and that protein synthesis may be necessary for IL 1's action. However, a physiological/pathological role for IL 1 in ovarian regulation has yet to be established.


This article has been cited by other articles:


Home page
 Biol. Reprod.Home page
S. Kol, B. W. Donesky, K. Ruutiainen-Altman, I. Ben-Shlomo, M. Irahara, M. Ando, R. M. Rohan, and E. Y. Adashi
Ovarian Interleukin-1 Receptor Antagonist in Rats: Gene Expression, Cellular Localization, Cyclic Variation, and Hormonal Regulation of a Potential Determinant of Interleukin-1 Action
Biol Reprod, July 1, 1999; 61(1): 274 - 282.
[Abstract] [Full Text]

Home page
 Reproductive SciencesHome page
W. J. Scherzer, K. S. L. Ruutiainen-Altman, L. T. Putowski, S. Kol, E. Y. Adashi, and R. M. Rohan
Detection and In Vivo Hormonal Regulation of Rat Ovarian Type I and Type II Interleukin-I Rececptor mRNAs: Increased Expression During the Periovulatory Period
Reproductive Sciences, May 1, 1996; 3(3): 131 - 139.
[Abstract] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1988 by The Federation of American Societies for Experimental Biology.